SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	582.38	942.06	166.83	332.23	633.03
Trading Asset Securities	110.37	89	97.55	360.4	-
Cash & Short-Term Investments	692.76	1,031	264.37	692.63	633.03
Cash Growth	-32.81%	290.00%	-61.83%	9.42%	-37.91%
Accounts Receivable	289.51	307.37	173.57	82.98	337.75
Other Receivables	-	0.15	31.1	265.59	519.65
Receivables	289.51	307.52	204.67	348.56	857.4
Inventory	620.9	529.53	513.43	294.18	380.88
Other Current Assets	57.22	85.13	59.93	61.93	47.5
Total Current Assets	1,660	1,953	1,042	1,397	1,919
Property, Plant & Equipment	4,803	3,912	3,194	2,100	1,503
Long-Term Investments	237.52	241.62	208.04	124.97	753.65
Other Intangible Assets	37.77	46.15	54.58	60.29	41.32
Long-Term Deferred Tax Assets	143.82	153.28	167.25	241.55	263.55
Other Long-Term Assets	318.06	384.69	294.11	265.64	89.89
Total Assets	7,201	6,691	4,961	4,190	4,570
Accounts Payable	58.44	44.25	48.64	33.78	80.88
Accrued Expenses	116.05	110.72	128.35	121.46	204.76
Short-Term Debt	0.1	175	112	-	-
Current Portion of Long-Term Debt	403.44	20	-	-	-
Current Portion of Leases	2.47	1.95	0.83	1.58	1.34
Current Income Taxes Payable	85.25	11.54	3.86	-	127.49
Current Unearned Revenue	94.92	38.37	31.77	41.76	97.3
Other Current Liabilities	253.72	168.07	444.86	549.35	610.45
Total Current Liabilities	1,014	569.89	770.32	747.94	1,122
Long-Term Debt	578.01	842.67	432.36	-	-
Long-Term Leases	6.37	2.86	0.2	0.57	1.25
Long-Term Unearned Revenue	-	-	4.11	-	-
Long-Term Deferred Tax Liabilities	104.45	146	103.81	103.81	103.81
Other Long-Term Liabilities	8.68	7.84	1	-	-
Total Liabilities	1,724	1,591	1,331	869.26	1,248
Common Stock	1,195	1,195	953.82	953.82	794.85
Additional Paid-In Capital	2,235	2,234	1,357	1,348	1,348
Retained Earnings	2,037	1,646	1,373	1,067	1,208
Comprehensive Income & Other	10.07	25.46	-54.73	-48.93	-29.38
Shareholders' Equity	5,477	5,100	3,629	3,321	3,322
Total Liabilities & Equity	7,201	6,691	4,961	4,190	4,570
Total Debt	990.39	1,042	545.38	2.16	2.59
Net Cash (Debt)	-297.63	-11.42	-281.01	690.48	630.44
Net Cash Growth	-	-	-	9.52%	-37.98%
Net Cash Per Share	-2.48	-0.10	-2.61	6.42	5.84
Filing Date Shares Outstanding	119.51	119.51	107.3	107.3	107.3
Total Common Shares Outstanding	119.51	119.51	107.3	107.3	107.3
Working Capital	646.01	1,383	272.08	649.37	796.6
Book Value Per Share	45.83	42.67	33.82	30.95	30.96
Tangible Book Value	5,439	5,054	3,575	3,260	3,281
Tangible Book Value Per Share	45.51	42.29	33.31	30.38	30.58
Land	687.88	687.88	687.88	825.68	825.68
Buildings	722.9	707	700.23	684.47	553.52
Machinery	2,467	1,786	1,185	577.08	576.8
Construction In Progress	1,965	1,565	1,323	633.3	222.71

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.